A Phase 3, randomized, double-blind, controlled trial of

  • Jha, Gautam (PI)

Project: Research project

Project Details

Description

A Phase 3, randomized, double-blind, controlled trial of cabozantinib (XL184) vs. mitoxantrone plus prednisone in men with previously treated symptomatic castration-resistant prostate cancer
StatusFinished
Effective start/end date8/1/1311/30/18

Funding

  • Exelixis Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.